The concomitant usage of buprenorphine and CYP3A4 inducers can reduce the plasma focus of buprenorphine [see CLINICAL PHARMACOLOGY], perhaps causing reduced efficacy or onset of the withdrawal syndrome in sufferers who have made Actual physical dependence to buprenorphine.Alert people of the symptoms of serotonin syndrome and to hunt healthcare int